• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠大流行进程对 STEMI 患者时间线的影响。

Effect of Covid-19 pandemic process on STEMI patients timeline.

机构信息

Department of Cardiology, Faculty of Medicine, Ondokuz Mayis University, Samsun, Turkey.

Department of Cardiology, Samsung Education and Research Hospital, Samsun, Turkey.

出版信息

Int J Clin Pract. 2021 May;75(5):e14005. doi: 10.1111/ijcp.14005. Epub 2021 Jan 21.

DOI:10.1111/ijcp.14005
PMID:33400345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7883118/
Abstract

OBJECTIVE

Delayed revascularisation in patients with ST-segment elevation myocardial infarction (STEMI) is associated with poor prognosis. The aim of this study is to investigate how the timeline in STEMI treatment was affected during the Covid-19 outbreak.

METHOD

Consecutive 165 STEMI patients were enrolled in the study during the Covid-19 pandemic period (Pandemic period) and the prepandemic period (Control period). The time period until patients' leaving their current position after the onset of pain (home delay), the time from the onset of pain to the first medical contact (FMC delay), door-to-balloon time, procedure time and hospitalisation time were recorded.

RESULTS

A total of 165 patients, 82 in the Pandemic period and 83 in the Control period, were included in the study. When compared with the control period, home delay [30 (5-6912) minutes vs 165 (10-360) minutes, P < .001] and FMC delay [61 (20-6932) minutes vs 190 (15-3660) minutes, P < .001] were significantly prolonged during the pandemic period. In addition, non-IRA PCI rate (8.8% vs 19.3% P = .043) and hospitalisation time [71 (15-170) vs 74.2 (37-329) hours, P = .045] were decreased.

CONCLUSION

During the Covid-19 pandemic period, prolonged prehospital time parameters were observed in STEMI patients. Therefore, additional measures may be required to prevent unfavourable delays in STEMI patients during the outbreak.

摘要

目的

ST 段抬高型心肌梗死(STEMI)患者的延迟再血管化与预后不良相关。本研究旨在探讨 COVID-19 大流行期间 STEMI 治疗的时间线是如何受到影响的。

方法

在 COVID-19 大流行期间(大流行期间)和大流行前期间(对照期间),连续纳入 165 例 STEMI 患者。记录患者自疼痛发作后离开当前位置的时间(家庭延迟)、自疼痛发作至首次医疗接触的时间(FMC 延迟)、门球时间、手术时间和住院时间。

结果

共纳入 165 例患者,大流行期间 82 例,对照期间 83 例。与对照期间相比,大流行期间家庭延迟[30(5-6912)分钟 vs. 165(10-360)分钟,P<.001]和 FMC 延迟[61(20-6932)分钟 vs. 190(15-3660)分钟,P<.001]显著延长。此外,非 IRA PCI 率(8.8% vs. 19.3%,P=.043)和住院时间[71(15-170)小时 vs. 74.2(37-329)小时,P=.045]降低。

结论

在 COVID-19 大流行期间,STEMI 患者的院前时间参数延长。因此,在疫情期间可能需要采取额外的措施来防止 STEMI 患者出现不利的延迟。

相似文献

1
Effect of Covid-19 pandemic process on STEMI patients timeline.新冠大流行进程对 STEMI 患者时间线的影响。
Int J Clin Pract. 2021 May;75(5):e14005. doi: 10.1111/ijcp.14005. Epub 2021 Jan 21.
2
Impact of the COVID-19 pandemic on time to treatment, treatment patterns and outcomes among patients with acute coronary syndrome in Yogyakarta, Indonesia: a retrospective cohort study.印尼日惹雅加达急性冠状动脉综合征患者 COVID-19 大流行对治疗时间、治疗模式和结局的影响:一项回顾性队列研究。
BMJ Open. 2024 Oct 14;14(10):e079060. doi: 10.1136/bmjopen-2023-079060.
3
Impact of COVID-19 pandemic on STEMI undergoing primary PCI treatment in Beijing, China.中国北京 COVID-19 大流行对 STEMI 患者行直接经皮冠状动脉介入治疗的影响。
Am J Emerg Med. 2022 Mar;53:68-72. doi: 10.1016/j.ajem.2021.11.034. Epub 2021 Nov 24.
4
The impact of COVID-19 on short-term prognosis of ST-segment elevation myocardial infarction patients receiving primary percutaneous coronary intervention in Wuhan China.COVID-19 对中国武汉行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者短期预后的影响。
Rev Cardiovasc Med. 2021 Mar 30;22(1):247-256. doi: 10.31083/j.rcm.2021.01.243.
5
Impact of the COVID-19 pandemic on acute coronary syndromes.COVID-19 大流行对急性冠状动脉综合征的影响。
Swiss Med Wkly. 2020 Dec 31;150:w20448. doi: 10.4414/smw.2020.20448. eCollection 2020 Dec 14.
6
ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France.ST 段抬高型心肌梗死:法国 COVID-19 大流行期间的管理和预后相关性。
Arch Cardiovasc Dis. 2021 May;114(5):340-351. doi: 10.1016/j.acvd.2021.01.005. Epub 2021 Apr 14.
7
Initial Single-Center ST-Segment Elevation Myocardial Infarction Experience in New York Before and During the COVID-19 Pandemic.在 COVID-19 大流行前后纽约的初始单中心 ST 段抬高型心肌梗死经验。
Cardiovasc Revasc Med. 2022 Jan;34:80-85. doi: 10.1016/j.carrev.2021.01.026. Epub 2021 Jan 26.
8
Impact of the COVID-19 Pandemic on Patient Delay and Clinical Outcomes for Patients With Acute Myocardial Infarction.COVID-19 大流行对急性心肌梗死患者的就诊延迟和临床结局的影响。
J Korean Med Sci. 2022 May 30;37(21):e167. doi: 10.3346/jkms.2022.37.e167.
9
Care and Outcomes of ST-Segment Elevation Myocardial Infarction Across Multiple COVID-19 Waves.多次 COVID-19 波次中 ST 段抬高型心肌梗死的护理与结局。
Can J Cardiol. 2022 Jun;38(6):783-791. doi: 10.1016/j.cjca.2022.01.033. Epub 2022 Feb 10.
10
Impact of COVID-19 Pandemic on Patients with ST-Segment-Elevation Myocardial Infarction Complicated by Out-of-Hospital Cardiac Arrest.COVID-19 大流行对合并院外心脏骤停的 ST 段抬高型心肌梗死患者的影响。
Int J Environ Res Public Health. 2022 Dec 26;20(1):337. doi: 10.3390/ijerph20010337.

引用本文的文献

1
The impact of the COVID-19 pandemic on ST-segment elevation myocardial infarction treatment strategy and outcomes.2019年冠状病毒病大流行对ST段抬高型心肌梗死治疗策略及预后的影响。
Front Cardiovasc Med. 2025 Apr 16;12:1522661. doi: 10.3389/fcvm.2025.1522661. eCollection 2025.
2
Current situation of acute ST-segment elevation myocardial infarction in a county hospital chest pain center during an epidemic of novel coronavirus pneumonia.新型冠状病毒肺炎疫情期间某县级医院胸痛中心急性ST段抬高型心肌梗死的现状
Open Med (Wars). 2023 Jan 9;18(1):20220621. doi: 10.1515/med-2022-0621. eCollection 2023.
3
Impact of SARS-CoV-2 Outbreak on Emergency Department Presentation and Prognosis of Patients with Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis.2019冠状病毒病疫情对急性心肌梗死患者急诊科就诊情况及预后的影响:一项系统评价与更新的荟萃分析
J Clin Med. 2022 Apr 21;11(9):2323. doi: 10.3390/jcm11092323.
4
The Impact of the COVID-19 Pandemic on Hospital Services for Patients with Cardiac Diseases: A Scoping Review.COVID-19 大流行对心脏病患者医院服务的影响:范围综述。
Int J Environ Res Public Health. 2022 Mar 8;19(6):3172. doi: 10.3390/ijerph19063172.
5
Impact of respiratory infectious epidemics on STEMI incidence and care.呼吸感染性流行病对 STEMI 发病率和治疗的影响。
Sci Rep. 2021 Nov 29;11(1):23066. doi: 10.1038/s41598-021-02480-z.
6
Investigating the implications of COVID-19 outbreak on systems of care and outcomes of STEMI patients: A systematic review and meta-analysis.探讨 COVID-19 疫情对 STEMI 患者的护理系统和结局的影响:系统评价和荟萃分析。
Indian Heart J. 2021 Jul-Aug;73(4):404-412. doi: 10.1016/j.ihj.2021.06.009. Epub 2021 Jun 25.
7
Delayed Presentation During COVID-19 Pandemic Leading to Post-Myocardial Infarction Ventricular Septal Defect.新冠疫情期间延迟就诊导致心肌梗死后室间隔缺损
Cureus. 2021 Jun 26;13(6):e15945. doi: 10.7759/cureus.15945.
8
The Global Effect of the COVID-19 Pandemic on STEMI Care: A Systematic Review and Meta-analysis.《COVID-19 大流行对 STEMI 治疗的全球影响:系统评价和荟萃分析》。
Can J Cardiol. 2021 Sep;37(9):1450-1459. doi: 10.1016/j.cjca.2021.04.003. Epub 2021 Apr 20.

本文引用的文献

1
Hospital admissions for acute myocardial infarction before and after lockdown according to regional prevalence of COVID-19 and patient profile in France: a registry study.根据法国 COVID-19 区域性流行情况和患者特征,封锁前后因急性心肌梗死住院的情况:一项注册研究。
Lancet Public Health. 2020 Oct;5(10):e536-e542. doi: 10.1016/S2468-2667(20)30188-2. Epub 2020 Sep 18.
2
Review on the coronavirus disease (COVID-19) pandemic: Its outbreak and current status.关于冠状病毒病(COVID-19)大流行的综述:其爆发和现状。
Int J Clin Pract. 2020 Nov;74(11):e13637. doi: 10.1111/ijcp.13637. Epub 2020 Aug 27.
3
Patient and system delays in the treatment of acute coronary syndrome.急性冠状动脉综合征的患者和系统延误治疗。
Rev Port Cardiol (Engl Ed). 2020 Mar;39(3):123-131. doi: 10.1016/j.repc.2019.07.007. Epub 2020 May 6.
4
[Impact of different admission ways on treatment efficiency in patients with acute ST-segment elevation myocardial infarction].[不同入院方式对急性ST段抬高型心肌梗死患者治疗效率的影响]
Zhonghua Xin Xue Guan Bing Za Zhi. 2020 Apr 24;48(4):302-307. doi: 10.3760/cma.j.cn112148-20190815-00494.
5
[Consensus Report from Turkish Society of Cardiology: COVID-19 and Cardiovascular Diseases. What cardiologists should know. (25th March 2020)].[土耳其心脏病学会共识报告:2019冠状病毒病与心血管疾病。心脏病专家应了解的内容。(2020年3月25日)]
Turk Kardiyol Dern Ars. 2020 Mar;48(Suppl 1):1-48. doi: 10.5543/tkda.2020.97198.
6
CSC Expert Consensus on Principles of Clinical Management of Patients With Severe Emergent Cardiovascular Diseases During the COVID-19 Epidemic.《新型冠状病毒肺炎流行期间心血管急危重症患者临床管理专家共识》
Circulation. 2020 May 19;141(20):e810-e816. doi: 10.1161/CIRCULATIONAHA.120.047011. Epub 2020 Mar 27.
7
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China.2019年冠状病毒病(COVID-19)疫情对中国香港ST段抬高型心肌梗死治疗的影响
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631. doi: 10.1161/CIRCOUTCOMES.120.006631. Epub 2020 Mar 17.
8
[2018 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and European Association for Cardio-Thoracic Surgery (EACTS)].[2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。欧洲心脏病学会(ESC)和欧洲心胸外科学会(EACTS)心肌血运重建特别工作组]
G Ital Cardiol (Rome). 2019 Jul-Aug;20(7-8 Suppl 1):1S-61S. doi: 10.1714/3203.31801.
9
Factors influencing patient delay before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: The Stent for life initiative in Portugal.影响ST段抬高型心肌梗死患者在接受直接经皮冠状动脉介入治疗前延迟的因素:葡萄牙的“生命支架”倡议
Rev Port Cardiol (Engl Ed). 2018 May;37(5):409-421. doi: 10.1016/j.repc.2017.07.014. Epub 2018 May 8.
10
Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial.治疗延迟对伴或不伴血液动力学不稳定的 ST 段抬高型心肌梗死(STEMI)患者死亡率的影响:来自德国前瞻性、多中心 FITT-STEMI 试验的结果。
Eur Heart J. 2018 Apr 1;39(13):1065-1074. doi: 10.1093/eurheartj/ehy004.